1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6DC65C123CCC84FA7652580A7001D9B0A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-healthcare-digital-marketing-innovation-customer-engagement-content-approval-tactics?opendocument
18
19opendocument
203.88.220.93
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Digital Marketing

Healthcare Digital Marketing Innovation: Customer Engagement and Content Approval Tactics

ID: 5446


Features:

9 Info Graphics

17 Data Graphics

290+ Metrics

9 Narratives


Pages/Slides: 33


Published: 2017


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from Healthcare Digital Marketing Innovation: Customer Engagement and Content Approval Tactics”

STUDY OVERVIEW

Healthcare organizations are investing more than ever in digital marketing to learn about their customers, build better relationships and maximize revenue. To gain a competitive edge, companies must continue to innovate and identify the right channels, tools and approaches to reach customers.

Best Practices, LLC undertook benchmarking research to probe how savvy biopharma digital marketers are expanding the reach and effectiveness of digital customer engagement through emerging channels, measuring ROI for innovative activities, and enhancing the digital content and program review and approval process.

Insights in this study are segmented by: Company Size – Large Companies and Medium and Small Companies, Team - Global Teams and U.S. Only Teams.

KEY TOPICS


I. Innovative Engagement Activities:
  • Measuring ROI
  • Dynamic use of video and social media
  • Electronic Health Records programs
  • Addressing Integrated Delivery Networks

II. Enhancing Content Review:
  • Better collaboration with Medical-Regulatory-Legal approval partners
  • Effective content approval tactics

KEY METRICS

  • Demonstrated ROI for Innovative Digital Activities
  • ROI vs. Usage of Innovative Digital Activities
  • Most Heavily Used Social Platforms
  • Innovative Use of Social Media by Participants over the Past Year
  • Tactics to Support the Expanded Use of Electronic Health Records (EHRs) by Physicians
  • Steps Undertaken to Grow Digital Engagement with Integrated Delivery Networks (IDNs)
  • Effective Approaches for Improving Collaboration between Digital Marketing Group and Medical, Regulatory, and Legal Approval Teams
  • Effective Tactics for Expediting Internal Approvals of Key Digital Content and Programs

SAMPLE KEY FINDINGS

  • Establish Open Communication Channels & Use Standardized Templates to Improve Medical-Regulatory-Legal Collaboration: The top-ranked tactic for improving collaborations with Medical, Regulatory and Legal review teams is to create an open communications channel between all stakeholders - 52% find this highly effective. Some 48% have found the introduction of standardized digital processes and templates to be highly effective. Finally, most companies (81%) find senior management support an at least somewhat effective way of improving the content approval process.

METHODOLOGY


Best Practices, LLC engaged 31 digital, multichannel marketing and other commercial leaders from 24 leading healthcare organizations through a benchmarking survey instrument. Nearly 70% of participants serve at the level of director or above.


Industries Profiled:
Biopharmaceutical; Pharmaceutical; Medical Device; Manufacturing; Biotech; Consumer Products; Diagnostic; Health Care; Chemical; Consulting; Education


Companies Profiled:
Alkermes; Astellas; Baxter International; Bayer; CSL Behring; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline ; Insyght; Integra LifeSciences; MediMedia; Merck; Mylan; Nektar Therapeutics; Novartis; Pfizer; Precision For Value; Prometheus Therapeutics & Diagnostics; Roche; Shionogi Inc.; Sunovion; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.